Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

ARM

Analyzing the Reasons Behind ARM's Stock Decline

After this morning's -1.7% drop to $125.95 per share, Series might just keep moving past its target price of $131.81. With an average analyst rating of buy, and target prices from $73.0 to $180.0, the stock's next move is anyone's guess.

Series has an elevated short interest of 12.6%. The stock's short ratio, or the number of days needed for all shorts to cover their positions, is 3.05. The company's insiders own 87.45% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Series's rate of institutional ownership stands at 8.0%, which is lower than average and further confirms the lack of market confidence in the stock. As a result, Market Inference considers Series to be the subject of mixed market sentiment.

Institutions Invested in Series

Date Reported Holder Percentage Shares Value
2025-03-31 Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main 0% 5,204,100 $655,456,379
2025-03-31 Capital World Investors 0% 4,932,888 $621,297,228
2025-03-31 Goldman Sachs Group Inc 0% 3,690,654 $464,837,860
2025-03-31 Blackrock Inc. 0% 3,466,298 $436,580,222
2025-03-31 Schroder Investment Management Group 0% 3,349,273 $421,840,924
2025-03-31 Artisan Partners Limited Partnership 0% 3,338,996 $420,546,536
2025-03-31 Morgan Stanley 0% 3,158,186 $397,773,517
2025-03-31 UBS Group AG 0% 2,855,025 $359,590,390
2025-03-31 BNP Paribas Financial Markets 0% 2,189,108 $275,718,145
2025-03-31 Alphabet Inc. 0% 1,960,784 $246,960,738
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS